These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36057266)

  • 21. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
    Grabowski F; Kochańczyk M; Lipniacki T
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study.
    Mabuka T; Naidoo N; Ncube N; Yiga T; Ross M; Kurehwa K; Nare Nyathi M; Silaji A; Ndemera T; Lemeke T; Taiwo R; Macharia W; Sithole M
    JMIRx Med; 2023; 4():e34598. PubMed ID: 37463043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Has Omicron Changed the Evolution of the Pandemic?
    Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba.
    Pérez-Santosa L; Kourí-Cardellá V; Tejero-Suárez Y; Macías-Roig LM; Pintos-Saavedra Y; Medero-Díaz D; Figueredo-Amador C; Naranjo-González C; Morales-Arredondo D; Tamayo-Pérez NE; Martínez-Montesino Y; López-Almaguer Y; de Armas-Fernández JR; Portal-Miranda JA; Guzmán-Tirado MG
    MEDICC Rev; 2022 Oct; 24(3-4):18-23. PubMed ID: 36417330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.
    Yu Y; Yu Y; Zhao S; He D
    Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022.
    Chiwandire N; Jassat W; Groome M; Kufa T; Walaza S; Wolter N; von Gottberg A; Zar HJ; Reubenson G; Tempia S; Ebonwu J; Govender N; Ntshoe G; Shonhiwa AM; Blumberg L; Cohen C
    J Pediatric Infect Dis Soc; 2023 Apr; 12(3):128-134. PubMed ID: 36648247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
    Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
    Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Statistical Learning to Identify Omicron Mutations in SARS-CoV-2 Viral Genome Sequence Data From Populations in Africa and the United States.
    Zhao LP; Lybrand TP; Gilbert P; Madeleine M; Payne TH; Cohen S; Geraghty DE; Jerome KR; Corey L
    JAMA Netw Open; 2022 Sep; 5(9):e2230293. PubMed ID: 36069983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracking and controlling the spatiotemporal spread of SARS-CoV-2 Omicron variant in South Africa.
    Tong C; Shi W; Zhang A; Shi Z
    Travel Med Infect Dis; 2022; 46():102252. PubMed ID: 34973454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using generalized structured additive regression models to determine factors associated with and clusters for COVID-19 hospital deaths in South Africa.
    Maposa I; Welch R; Ozougwu L; Arendse T; Mudara C; Blumberg L; Jassat W
    BMC Public Health; 2023 May; 23(1):830. PubMed ID: 37147648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report.
    Giandhari J; Pillay S; Wilkinson E; Tegally H; Sinayskiy I; Schuld M; Lourenco J; Chimukangara B; Lessells R; Moosa Y; Gazy I; Fish M; Singh L; Khanyile KS; Fonseca V; Giovanetti M; Alcantara LC; Petruccione F; de Oliveira T
    medRxiv; 2020 May; ():. PubMed ID: 32511505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality trends and differentials in South Africa from 1997 to 2012: second National Burden of Disease Study.
    Pillay-van Wyk V; Msemburi W; Laubscher R; Dorrington RE; Groenewald P; Glass T; Nojilana B; Joubert JD; Matzopoulos R; Prinsloo M; Nannan N; Gwebushe N; Vos T; Somdyala N; Sithole N; Neethling I; Nicol E; Rossouw A; Bradshaw D
    Lancet Glob Health; 2016 Sep; 4(9):e642-53. PubMed ID: 27539806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).
    Yang W; Shaman J
    medRxiv; 2022 Jun; ():. PubMed ID: 34981071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.